-+ 0.00%
-+ 0.00%
-+ 0.00%

Pharma Equity Group Board Authorizes Up to DKK 4.13 Million in Convertible Loans

PUBT·11/09/2026 14:52:24
Listen to the news
Pharma Equity Group Board Authorizes Up to DKK 4.13 Million in Convertible Loans
  • Pharma Equity Group's board resolved on November 9, 2026, to issue convertible loans of up to DKK 4.13 million.
  • The issuance includes repayment of existing convertible loans with principal amounts of DKK 2 million and DKK 880,592.
  • The new loans carry 10% annual interest, with conversion at DKK 0.10 per share.
  • Conversion could increase nominal share capital by up to DKK 5.43 million, without preemptive rights for existing shareholders.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharma Equity Group A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611090951OMX_____CNEWS_EN_GNW1001302640_en) on November 09, 2026, and is solely responsible for the information contained therein.